NET LOSS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three months ended March 31 (in thousands, except for per share amounts):

	Three Months Ended March 31,
	2024		2023
Loss from continuing operations, net noncontrolling interests and accrued preferred stock dividends	$	(18,653)	$	(71,362)
Loss from discontinued operations	(9,865)		(115,543)
Net loss attributable to NeueHealth, Inc. common shareholders	$	(28,518)	$	(186,905)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted	8,079		7,894
Basic and diluted loss per share attributable to NeueHealth, Inc. common shareholders
Continuing operations	$	(2.31)	$	(9.04)
Discontinued operations	$	(1.22)	$	(14.64)
Net loss per share attributable to common stockholders, basic and diluted	$	(3.53)	$	(23.68)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect for the three months ended March 31 (in thousands):

	Three Months Ended March 31,
	2024	2023
Redeemable convertible preferred stock (as converted to common stock)	4,867	4,031
Issued and outstanding common stock warrants	1,834	—
Stock options to purchase common stock	614	771
Restricted stock units	575	999
Total	7,890	5,801